Full Text:   <2229>

Summary:  <1707>

CLC number: R69

On-line Access: 2014-08-05

Received: 2014-04-14

Revision Accepted: 2014-07-08

Crosschecked: 2014-07-18

Cited: 0

Clicked: 4241

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B 2014 Vol.15 No.8 P.756-760

http://doi.org/10.1631/jzus.B1400100


Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy


Author(s):  You-yun Zhang1, Zhi-gen Zhang1, Yan-lan Yu1, Yi-cheng Chen1, Kang-xin Ni1, Ming-chao Wang1, Wei-ping Zhao1, Faisal Rehman1, Shaw P. Wan2, Gong-hui Li1

Affiliation(s):  1. Department of Urology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China; more

Corresponding email(s):   ligonghui1970@hotmail.com

Key Words:  Prostate cancer, Brachytherapy, Transurethral resection of the prostate (TURP)


Share this article to: More <<< Previous Article|

You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li. Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy[J]. Journal of Zhejiang University Science B, 2014, 15(8): 756-760.

@article{title="Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy",
author="You-yun Zhang, Zhi-gen Zhang, Yan-lan Yu, Yi-cheng Chen, Kang-xin Ni, Ming-chao Wang, Wei-ping Zhao, Faisal Rehman, Shaw P. Wan, Gong-hui Li",
journal="Journal of Zhejiang University Science B",
volume="15",
number="8",
pages="756-760",
year="2014",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1400100"
}

%0 Journal Article
%T Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy
%A You-yun Zhang
%A Zhi-gen Zhang
%A Yan-lan Yu
%A Yi-cheng Chen
%A Kang-xin Ni
%A Ming-chao Wang
%A Wei-ping Zhao
%A Faisal Rehman
%A Shaw P. Wan
%A Gong-hui Li
%J Journal of Zhejiang University SCIENCE B
%V 15
%N 8
%P 756-760
%@ 1673-1581
%D 2014
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1400100

TY - JOUR
T1 - Early channel transurethral resection of the prostate for patients with urinary retention after brachytherapy
A1 - You-yun Zhang
A1 - Zhi-gen Zhang
A1 - Yan-lan Yu
A1 - Yi-cheng Chen
A1 - Kang-xin Ni
A1 - Ming-chao Wang
A1 - Wei-ping Zhao
A1 - Faisal Rehman
A1 - Shaw P. Wan
A1 - Gong-hui Li
J0 - Journal of Zhejiang University Science B
VL - 15
IS - 8
SP - 756
EP - 760
%@ 1673-1581
Y1 - 2014
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1400100


Abstract: 
Objective: It is recommended that transurethral resection of the prostate (TURP) after brachytherapy should not be performed at an early stage after implantation. Herein we report our experiences and the results of channel TURP (cTURP) within six months post-implant for patients with refractory urinary retention. Methods: One hundred and ninety patients with localized prostate cancer of clinical stages T1c to T2c were treated by brachytherapy as monotherapy at our institution from February 2009 to July 2013. Nine patients who developed refractory urinary retention and underwent cTURP within six months after brachytherapy were retrospectively reviewed and analyzed. Results: The median interval between prostate brachytherapy and cTURP was three months (range 1.5 to 5.0 months). There were no intraoperative or postoperative complications and no incontinence resulting from the surgery. All urinary retention was relieved per the American brachytherapy Society urinary symptom score. With a mean follow-up time of 16 months (range 6 to 26 months) after cTURP, no patient experienced biochemical recurrence. The mean serum prostate-specific antigen (PSA) of the patients who underwent cTURP was 0.42 ng/ml (range 0.08 to 0.83 ng/ml) at the end of their follow-up. Conclusions: Early cTURP was found to be safe and effective in relieving urinary retention after brachytherapy and could be performed without compromising its therapeutic efficacy.

早期经尿道前列腺隧道式电切治疗前列腺癌近距离照射治疗术后尿潴留

研究目的:探讨早期经尿道前列腺隧道式电切治疗前列腺癌近距离照射治疗术后尿潴留的适应症及其对近距离照射治疗疗效的影响。
创新要点:前列腺癌近距离照射治疗已经成为75岁以上患者的首选,前列腺癌近距离照射治疗术后尿潴留发生率为1.5%~22.0%。经尿道前列腺电切常用于药物治疗无效的反复尿潴留患者,且手术时机多在近距离照射治疗术后6个月以后。经尿道前列腺隧道式电切治疗前列腺癌近距离照射治疗术后尿潴留可在6个月内进行,患者尿道症状从IV(出现尿潴留,需要导尿)下降为0级(没有症状)或I级(轻度,中度尿频,2~3次/晚),较术前改善明显,且对近距离照射治疗疗效无明显影响。
研究方法:浙江大学医学院附属邵逸夫医院2009年2月至2013年7月间所有接受前列腺癌近距离照射治疗的病例共190例,其中9例(4.7%)患者术后出现反复尿潴留,且早期行经尿道前列腺隧道式电切术治疗,回顾分析其临床资料。
重要结论:前列腺癌近距离照射治疗术后反复尿潴留,在严格防护下早期行经尿道前列腺隧道式电切是安全有效的,且电切后对近距离照射治疗疗效无明显影响。
早期;前列腺癌;近距离照射治疗;经尿道前列腺电切

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

References

[1] Aagaard, J., Jonler, M., Fuglsig, S., 1994. Total transurethral resection versus minimal transurethral resection of the prostate—a 10-year follow-up study of urinary symptoms, uroflowmetry and residual volume. Br J Urol, 74(3):333-336. 


[2] Augustin, H., Hammerer, P.G., Blonski, J., 2003. Differences in biopsy features between prostate cancers located in the transition zone and peripheral zone. BJU Int, 91(6):477-481. 


[3] Augustin, H., Erbersdobler, A., Graefen, M., 2003. Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy. Urology, 62(1):79-85. 


[4] Cavanagh, W., Blasko, J.C., Grimm, P.D., 2000. Transient elevation of serum prostate-specific antigen following 125I/103Pd brachytherapy for localized prostate cancer. Semin Urol Oncol, 18(2):160-165. 


[5] Cooperberg, M.R., Lubeck, D.P., Meng, M.V., 2004. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol, 22(11):2141-2149. 


[6] Flam, T., Chauveinc, L., Servois, V., 2000. Brachytherapy in the curative treatment of localized prostatic cancer. Prog Urol, (in French),10(1):3-13. 


[7] Flam, T.A., Peyromaure, M., Chauveinc, L., 2004. Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer. J Urol, 172(1):108-111. 


[8] Greenlee, R.T., Hill-Harmon, M.B., Murray, T., 2001. Cancer statistics, 2001. CA Cancer J Clin, 51(1):15-36. 


[9] Iannuzzi, C.M., Stock, R.G., Stone, N.N., 1999. PSA kinetics following I-125 radioactive seed implantation in the treatment of T1-T2 prostate cancer. Radiat Oncol Investig, 7(1):30-35. 


[10] Jo, Y., Junichi, H., Tomohiro, F., 2005. Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of lift. BJU Int, 96(1):43-47. 


[11] Kollmeier, M.A., Stock, R.G., Cesaretti, J., 2005. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol, 173(3):808-812. 


[12] Mazur, A.W., Thompson, I.M., 1991. Efficacy and morbidity of ‘channel’ TURP. Urology, 38(6):526-528. 


[13] Merrick, G.S., Butler, W.M., Wallner, K.E., 2003. Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys, 56(2):454-461. 


[14] Potters, L., Klein, E.A., Kattan, M.W., 2004. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy or permanent seed implantation. Radiother Oncol, 71(1):29-33. 


[15] Sakai, I., Harada, K., Kurahashi, T., 2006. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones. Int J Urol, 13(4):368-372. 


[16] Sehgal, A., Mandhani, A., Gupta, N., 2005. Can the need for palliative transurethral prostatic resection in patients with advanced carcinoma of the prostate be predicted?. J Endourol, 19(5):546-549. 


[17] Siegel, R., Naishadham, D., Jemal, A., 2013. Cancer statistics, 2013. CA Cancer J Clin, 63(1):11-30. 


[18] Stone, N.N., Stock, R.G., 2002. Complications following permanent prostate brachytherapy. Eur Urol, 41(4):427-433. 


[19] Storey, M.R., Landgren, R.C., Cottone, J.L., 1999. Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys, 43(3):565-570. 


[20] Wallner, K., Roy, J., Harrison, L., 1995. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys, 32(2):465-471. 


[21] Whitmore, W.F., Hilaris, B., Grabstald, H., 2002. Retropubic implantation of iodine 125 in the treatment of prostate cancer. J Urol, 167(2):981-983. 



Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2023 Journal of Zhejiang University-SCIENCE